Detection of urinary podocytes by flow cytometry in idiopathic membranous nephropathy

被引:10
|
作者
Mella, Alberto [1 ]
Deambrosis, Ilaria [2 ]
Mingozzi, Silvia [1 ]
Colla, Loredana [1 ]
Burdese, Manuel [1 ]
Giaretta, Fulvia [2 ]
Bruno, Stefania [2 ,3 ]
Camussi, Giovanni [3 ]
Boaglio, Elena [1 ]
Dolla, Caterina [1 ]
Clari, Roberta [1 ]
Biancone, Luigi [1 ]
机构
[1] Univ Turin, Div Nephrol Dialysis & Transplantat, Dept Med Sci, Citta Salute & Sci Hosp, I-8810126 Corso, Italy
[2] Citta Salute & Sci Hosp, Lab Nephrol & Immunopathol, Turin, Italy
[3] Univ Turin, Dept Med Sci, Turin, Italy
关键词
DISEASE-ACTIVITY; RECEPTOR; AUTOANTIBODIES; PROGRESSION; CELLS;
D O I
10.1038/s41598-020-73335-2
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Idiopathic membranous nephropathy (iMN) is considered an immune-mediated disease where circulating autoantibodies against podocyte targets (mainly the PLA(2)R) cause the deposition of in-situ subepithelial immune-complexes. The consequent podocyte damage may cause cell detachment in urine (Podocyturia-PdoU). PdoU has been assessed in different kidney diseases, but limited data are available in iMN. In this study all patients with a diagnosis of iMN between 15/12/1999-16/07/2014 were tested for PLA(2)R antibodies (Ab anti-PLA(2)R, ELISA kit) and PdoU by flow cytometry with anti-podocalyxin antibody. A semi-quantitative PdoU score was defined according to the percentage of podocalyxin positive cells normalized to the total volume of sample and set relative to the urine creatinine measured in the supernatant. PdoU was positive in 17/27 patients (63%; 1+score in 6/27-22.2%, 2+in 4/27-14.8%, 3+in 2/27-7.4%, 4+in 5/27-18.5%). Only 2/7 patients with complete remission showed a positive PdoU (1+) while all six patients without remission have significant PdoU. PdoU+was statistically correlated with the absence of remission and Ab anti-PLA(2)R+(p<0.05) but PdoU, analysed as a continuous variable, showed a non-linear correlation with proteinuria or PLA(2)R antibody levels also in the cohort of patients with two available PdoU tests. In conclusion, PdoU could be detected in iMN and seems to be associated with commonly considered markers of disease activity (proteinuria and Ab anti-PLA(2)R) with a non-linear correlation. Despite data should be confirmed in large and prospective cohorts, according to the podocyte depletion hypothesis PdoU may represent an early marker of immunological activation with potential prognostic utility.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Clinicopathological features and prognosis in patients with idiopathic membranous nephropathy with hypertension
    Lu, Wanjun
    Gong, Shuhao
    Li, Juan
    Wang, Ying
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2020, 19 (04) : 2615 - 2621
  • [22] Rituximab for the management of idiopathic membranous nephropathy: a meta-analysis
    Huang, Lan
    Dong, Qiao-Rong
    Zhao, Ya-Juan
    Hu, Gui-Cai
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2021, 53 (01) : 111 - 119
  • [23] Clinicopathological features and outcome in elderly patients with idiopathic membranous nephropathy
    Liang, Jinxiu
    Hao, Wenke
    Xia, Fangxiao
    Zhao, Zhi
    Wu, Yanhua
    Yu, Feng
    Hu, Wenxue
    Fang, Xiaowu
    Liu, Wei
    RENAL FAILURE, 2023, 45 (01)
  • [24] Serum BAFF levels are associated with the prognosis of idiopathic membranous nephropathy
    Li, Zhaohui
    Chen, Ping
    Zhang, Ying
    Chen, Juan
    Zheng, Shanshan
    Li, Wenbin
    Tang, Lijun
    Liu, Yipeng
    Zhao, Na
    RENAL FAILURE, 2024, 46 (02)
  • [25] Is There a Place for Apheresis in the Management of Idiopathic Membranous Nephropathy? A Report of Three Cases and Literature Review
    Bennani, Hamza Naciri
    Banza, Augustin Twite
    Giovannini, Diane
    Motte, Lionel
    Noble, Johan
    Corbu, Alexandra
    Malvezzi, Paolo
    Jouve, Thomas
    Rostaing, Lionel
    JOURNAL OF PERSONALIZED MEDICINE, 2024, 14 (03):
  • [26] Circulating miRNAs in extracellular vesicles related to treatment response in patients with idiopathic membranous nephropathy
    Sun, In O.
    Bae, Yun-Ui
    Lee, Haekyung
    Kim, Hyoungnae
    Jeon, Jin Seok
    Noh, Hyunjin
    Choi, Jong-Soo
    Doh, Kyung-Oh
    Kwon, Soon Hyo
    JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
  • [27] HLA-DR, and not PLA2R, is expressed on the podocytes in kidney allografts in de novo membranous nephropathy
    Wen, Jiqiu
    Xie, Kenan
    Zhang, Mingchao
    Chen, Jinsong
    Zhang, Jiong
    Cheng, Dongrui
    Li, Xue
    Ji, Shuming
    Liu, Zhihong
    MEDICINE, 2016, 95 (37)
  • [28] Clinicopathological features of idiopathic membranous nephropathy combined with IgA nephropathy: a retrospective analysis of 9 cases
    Hu, Ruimin
    Xing, Guolan
    Wu, Huijuan
    Zhang, Zhigang
    DIAGNOSTIC PATHOLOGY, 2016, 11
  • [29] Idiopathic membranous nephropathy in children treated with rituximab: report of two cases
    Malatesta-Muncher, Rossana
    Eldin, Karen W.
    Beck, Laurence H., Jr.
    Michael, Mini
    PEDIATRIC NEPHROLOGY, 2018, 33 (06) : 1089 - 1092
  • [30] A nomogram for the prediction of renal outcomes among patients with idiopathic membranous nephropathy
    Zhang, Ji
    Pan, Shufang
    Li, Duo
    Li, Zhanyuan
    Jin, Lingwei
    Zhou, Zhihong
    Pan, Min
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2020, 20 (04) : 3130 - 3137